Survey of chronic pain in Chile – prevalence and treatment, impact on mood, daily activities and quality of life
Por um escritor misterioso
Descrição
Background and aims The prevalence of chronic non-cancer pain has not been specifically reported in Chile. Methods In order to assess its prevalence and impact, we designed a tool based on previously published survey studies. We analyzed a sample of 784 subjects to determine the prevalence of chronic non-cancer pain, with a maximum variability of 50%, a confidence interval (CI) of 95%, and an estimation error of 3.5%. Finally, a cross-sectional cell phone survey was conducted on a nationally representative probability sample of 865 subjects of over 18 years, in November 2013. The prevalence of chronic non-cancer pain was estimated by using expansion factors according to national projections by age group and gender, from the Chilean National Institute of Statistics for the year 2010. Results The estimated prevalence of chronic non-cancer pain was 32.1% (95% CI: 26.5–36.0). The respondents with chronic non-cancer pain presented the following results: 65.7% had moderate pain, and 20.8%, severe pain; 65.6% had somatic pain, 31.7% neuropathic pain, and 2.7% visceral pain. Approximately 70% reported they were receiving some kind of pharmacological treatment with certain frequency. In 64.9%, medication was prescribed by a physician. The prevalence of sick leave in workers was 30.22%, with a median duration of 14 days (interquartile range: 14; range: 1–60). Conclusions Chronic non-oncological pain occurs in 32% of Chilean adults. These figures provide the first measurement of chronic non-cancer pain in the Chilean population. Implications Chronic non-oncological pain impact as a public health problem is revealed, given the high prevalence found, and the elevated private and social costs involved.
Epidemiology of haemodialysis outcomes
Frontiers Reducing stigma toward mental illness and substance use issues in primary health care in Chile: Protocol of a cluster controlled trial study
Early optimized pharmacological treatment in patients with depression and chronic pain, CNS Spectrums
PDF) Survey of chronic pain in Chile - Prevalence and treatment, impact on mood, daily activities and quality of life
Glutamatergic systems in neuropathic pain and emerging non-opioid therapies - ScienceDirect
The Global Burden of Headache: A Documentation of Headache Prevalence and Disability Worldwide - LJ Stovner, K Hagen, R Jensen, Z Katsarava, RB Lipton, AI Scher, TJ Steiner, J-A Zwart, 2007
PDF] Chronic pain in Canada--prevalence, treatment, impact and the role of opioid analgesia.
Two decades of data reveal overall increase in pain, opioid use among U.S. adults
PDF) Survey of chronic pain in Chile - Prevalence and treatment, impact on mood, daily activities and quality of life
Behavioral Sciences, Free Full-Text
PDF] Survey of chronic pain in Chile – prevalence and treatment, impact on mood, daily activities and quality of life
The 5% Lidocaine-Medicated Plaster: Its Inclusion in International Treatment Guidelines for Treating Localized Neuropathic Pain, and Clinical Evidence Supporting its Use – topic of research paper in Clinical medicine. Download scholarly article
PDF) Chronic pain: its impact on the quality of life and gender
The prevalence of chronic pain in United States adults: results of an Internet-based survey.
PDF) Survey of chronic pain in Chile - Prevalence and treatment, impact on mood, daily activities and quality of life
de
por adulto (o preço varia de acordo com o tamanho do grupo)
